Lung Cancer

Giotrif Drug Information

Friday, November 23rd, 2018

Giotrif is prescribed to patients diagnosed with non-small cell lung cancer that has spread to other parts of the body. Giotrif is a type of antiangiogenesis agent which belongs to a drug class known as kinase inhibitors. When used consistently, the medication helps to slow or stop the growth of cancerous cells.